Bradford Van Wagenen

Title: Bradford Van Wagenen: Innovator in Neurological Treatments

Introduction

Bradford Van Wagenen is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological diseases and disorders. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Van Wagenen holds a patent for "Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists." This invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors. These compounds are particularly useful for treating various neurological diseases and disorders. The patent also discloses methods for preparing these compounds, highlighting the practical applications of his research.

Career Highlights

Throughout his career, Bradford Van Wagenen has worked with prominent companies in the pharmaceutical industry. He has been associated with NPS Pharmaceuticals, Inc. and AstraZeneca AB, where he contributed to the development of innovative treatments. His experience in these organizations has enriched his knowledge and skills in the field of drug development.

Collaborations

Van Wagenen has collaborated with notable professionals in his field, including Thomas M. Stormann and Scott T. Moe. These collaborations have likely enhanced his research and contributed to the success of his inventions.

Conclusion

Bradford Van Wagenen is a distinguished inventor whose work in developing compounds for neurological treatments has made a significant impact. His patent and career achievements reflect his commitment to advancing medical science and improving patient outcomes.